Procedural Codes/J3530

J3530 HCPCS 2026 Code: Nasal vaccine inhalation

J3530 is the authoritative medical code for Nasal vaccine inhalation. This classification is used in medical billing and clinical recording to specify the clinical criteria for nasal vaccine inhalation (HCPCS Level II J3530), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

Nasal vaccine inhalation is a HCPCS Level II code J3530 for a Medicare-covered supply, service, or procedure.

Codes in This Family (5)

Official HCPCS Level II classifications in the same code family as J3530, with their registry titles.

  • J3520 — Edetate disodium, per 150 mg
  • J3535 — Drug administered through a metered dose inhaler
  • J3570 — Laetrile, amygdalin, vitamin b17
  • J3590 — Unclassified biologics
  • J3591 — Unclassified drug or biological used for esrd on dialysis

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code J3525 Drugs Administered Other than Oral Method
HCPCS Code J3526 Drugs Administered Other than Oral Method
HCPCS Code J3527 Drugs Administered Other than Oral Method
HCPCS Code J3528 Drugs Administered Other than Oral Method
HCPCS Code J3529 Drugs Administered Other than Oral Method
HCPCS Code J3531 Drugs Administered Other than Oral Method
HCPCS Code J3532 Drugs Administered Other than Oral Method
HCPCS Code J3533 Drugs Administered Other than Oral Method
HCPCS Code J3534 Drugs Administered Other than Oral Method
HCPCS Code J3535 Drug administered through a metered dose inhaler
MedCoder.aiClinical Desktop
MedCoder Clinical Desktop Active|v1.0.0